What is the treatment for hyperemesis gravidarum?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Hyperemesis Gravidarum

The treatment of hyperemesis gravidarum follows a stepwise approach, beginning with first-line antiemetics such as doxylamine/pyridoxine and phenothiazines, progressing to second-line agents like metoclopramide and ondansetron, and utilizing corticosteroids for refractory cases, alongside appropriate fluid and electrolyte replacement. 1

Definition and Clinical Presentation

  • Hyperemesis gravidarum (HG) is characterized by intractable nausea and vomiting during pregnancy, resulting in dehydration, weight loss ≥5% of pre-pregnancy weight, and ketonuria, affecting 0.3-2% of pregnancies 1
  • Symptoms typically begin before week 22 of gestation, with resolution in >50% of patients by week 16 and in 80% by week 20, though 10% may experience symptoms throughout pregnancy 2
  • HG is associated with elevated liver enzymes in 40-50% of cases, electrolyte imbalances, and potential nutritional deficiencies 2

Initial Assessment

  • Evaluate for signs of dehydration (orthostatic hypotension, decreased skin turgor, dry mucous membranes) 2
  • Check for malnutrition, neurologic signs of vitamin deficiencies, and electrolyte abnormalities 1
  • Laboratory evaluation should include liver function tests, electrolyte panel, and urinalysis for ketonuria 1
  • Abdominal ultrasonography helps detect multiple or molar pregnancies and rule out hepatobiliary, vascular, or renal causes of symptoms 2

Treatment Algorithm

First-Line Management

  • Immediate intravenous fluid resuscitation to correct dehydration 1
  • Thiamine supplementation (100 mg daily for minimum 7 days, followed by 50 mg daily maintenance) to prevent Wernicke's encephalopathy 2
  • First-line pharmacologic treatments include:
    • Doxylamine/pyridoxine combination 2, 1
    • Phenothiazines (chlorpromazine, prochlorperazine, promethazine) 2, 1
    • Cyclizine 2

Second-Line Management

  • If first-line treatments are ineffective, progress to:
    • Metoclopramide (similar efficacy to promethazine with fewer side effects) 2
    • Domperidone 2
    • Ondansetron (use on case-by-case basis, especially before 10 weeks of pregnancy) 2

Third-Line Management

  • For refractory cases:
    • Corticosteroids 2, 3
    • Alternative pharmacotherapeutics like mirtazapine, olanzapine, and gabapentin may be considered 3
    • Enteral or parenteral nutrition for prolonged cases with ongoing weight loss 3

Special Considerations

  • Monitor for QT interval prolongation with ondansetron, particularly in patients with electrolyte abnormalities 1
  • Drug-induced extrapyramidal adverse effects may occur with phenothiazines and metoclopramide 2
  • Persistent liver chemistry abnormalities despite symptom resolution should prompt investigation for another etiology 1

Monitoring and Follow-up

  • Regular assessment of hydration status and electrolyte balance 1
  • Fetal growth monitoring, especially with insufficient gestational weight gain 1
  • Educate patients about the high recurrence risk (40-92%) in subsequent pregnancies 1

Complications

  • Untreated HG is associated with low birth weight, small for gestational age infants, and premature delivery 2, 1
  • Severe nutritional deficiencies can lead to significant maternal morbidity if not addressed 3
  • Thiamine deficiency can lead to Wernicke's encephalopathy, a serious neurological complication 1, 4

Non-Pharmacological Approaches

  • Dietary modifications including small, frequent, bland meals, high-protein and low-fat meals 1
  • Avoidance of specific food triggers and strong odors 1
  • Ginger supplementation has shown some benefit 5

The management of hyperemesis gravidarum requires a comprehensive approach with prompt intervention to prevent complications and improve maternal quality of life and pregnancy outcomes.

References

Guideline

Hyperemesis Gravidarum Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Inpatient Management of Hyperemesis Gravidarum.

Obstetrics and gynecology, 2024

Research

The clinical management of hyperemesis gravidarum.

Archives of gynecology and obstetrics, 2011

Research

Hyperemesis gravidarum--assessment and management.

Australian family physician, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.